Tekla Capital Management’s Evolent Health EVH Stock Holding History

Tekla Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-231,027	Closed	-$1.65M	–	210
2020 Q2	$1.65M	Hold	231,027	–	–	0.06%	175
2020 Q1	$1.25M	Hold	231,027	–	–	0.06%	164
2019 Q4	$2.09M	Hold	231,027	–	–	0.08%	150
2019 Q3	$1.66M	Buy	231,027 +56,757	+33%	+$407K	0.07%	142
2019 Q2	$1.39M	Buy	174,270 +132,120	+313%	+$1.56M	0.06%	152
2019 Q1	$530K	Hold	42,150	–	–	0.02%	179
2018 Q4	$841K	Sell	42,150 -42,150	-50%	-$975K	0.04%	169
2018 Q3	$2.39M	Sell	84,300 -38,200	-31%	-$911K	0.09%	140
2018 Q2	$2.58M	Hold	122,500	–	–	0.1%	126
2018 Q1	$1.75M	Hold	122,500	–	–	0.07%	144
2017 Q4	$1.51M	Hold	122,500	–	–	0.06%	134
2017 Q3	$2.18M	Buy	+122,500	New	+$2.52M	0.08%	117

Other funds holding EVH

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Tekla Capital Management's EVH Position: Q3 2020 in Review

Tekla Capital Management sold out of Evolent Health (EVH) in Q3 2020, closing a stake of 231,027 shares — an estimated $1.65M sold.

Tekla Capital Management first reported a position in EVH in Q3 2017 and held it in 12 quarters. The position peaked at $2.58M in Q2 2018. 155 funds tracked by Wall St. Rank hold EVH as of Q3 2020.

Tekla Capital Management reported no remaining Evolent Health position as of Q3 2020 after selling out during the quarter.
Tekla Capital Management sold 231,027 Evolent Health shares in Q3 2020, an estimated $1.65M.
Tekla Capital Management first reported a position in Evolent Health in Q3 2017 and held it in 12 quarters.
Tekla Capital Management's Evolent Health position peaked at $2.58M in Q2 2018.
155 funds tracked by Wall St. Rank held Evolent Health as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.